Valentin Harter

发表

Comparison of COBAS 4800 KRAS, TaqMan PCR and High Resolution Melting PCR assays for the detection of KRAS somatic mutations in formalin-fixed paraffin embedded colorectal carcinomas

A. Leroux, J. Merlin, A. Harlé, 2013, Virchows Archiv.

Optimization of routine KRAS mutation PCR-based testing procedure for rational individualized first-line-targeted therapy selection in metastatic colorectal cancer

A. Leroux, J. Merlin, A. Chretien, 2013, Cancer medicine.

Chemotherapy for Muscle-invasive Bladder Cancer: Impact of Cisplatin Delivery on Renal Function and Local Control Rate in the Randomized Phase III VESPER (GETUG-AFU V05) Trial.

S. Culine, Y. Allory, W. Hilgers, 2021, Clinical genitourinary cancer.

Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients With Nonmetastatic Muscle-Invasive Bladder Cancer: Results of the GETUG-AFU V05 VESPER Trial

S. Culine, Y. Allory, G. Gravis, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analysis of PIK3CA exon 9 and 20 mutations in breast cancers using PCR-HRM and PCR-ARMS: correlation with clinicopathological criteria.

J. Merlin, A. Harlé, P. Génin, 2013, Oncology reports.

Landscape of pathogenic variations in a panel of 34 genes and cancer risk estimation from 5131 HBOC families

T. Frebourg, Baptiste Brault, P. Berthet, 2018, Genetics in Medicine.

Detecting splicing patterns in genes involved in hereditary breast and ovarian cancer

C. Houdayer, T. Frebourg, Baptiste Brault, 2017, European Journal of Human Genetics.

SPiP: Splicing Prediction Pipeline, a machine learning tool for massive detection of exonic and intronic variant effects on mRNA splicing

A. Spurdle, C. Houdayer, D. Vidaud, 2022, Human mutation.

Landscape of pathogenic variations in a panel of 34 genes and cancer risk estimation from 5131 HBOC families

T. Frebourg, Baptiste Brault, P. Berthet, 2018, Genetics in Medicine.

ORGAVADS: establishment of tumor organoids from head and neck squamous cell carcinoma to assess their response to innovative therapies

L. weiswald, E. Babin, J. Thariat, 2023, BMC Cancer.

The FREGAT biobank: a clinico-biological database dedicated to esophageal and gastric cancers

S. Msika, T. Conroy, M. Copin, 2018, BMC Cancer.

Refining the Characterization and Outcome of Pathological Complete Responders after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Lessons from the Randomized Phase III VESPER (GETUG-AFU V05) Trial

S. Culine, Y. Allory, G. Gravis, 2023, Cancers.

Outcomes according to histological variants of urothelial carcinoma after neoadjuvant chemotherapy in the GETUG-AFU V05 VESPER trial.

S. Culine, Y. Allory, C. Pfister, 2022, Journal of Clinical Oncology.

SpliceLauncher: a tool for detection, annotation and relative quantification of alternative junctions from RNAseq data

Raphaël Leman, Valentin Harter, Alexandre Atkinson, 2019, Bioinform..